By Erin Coe ( March 31, 2016, 12:27 AM EDT) -- Two patents behind Merck's $200 million jury trial victory last week are unenforceable, rival Gilead told a California federal judge at a follow-on bench trial Wednesday, saying an attorney who prosecuted one of Merck's hepatitis C drug patents lied in the process, tainting both patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.